Why Choose Between Wegovy vs Mounjaro at EverydayMeds?
Understanding the Key Differences When Swapping From Mounjaro to Wegovy
The primary distinction when swapping from Mounjaro to Wegovy lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This means you're moving from a dual-action approach to a single-pathway treatment that has been extensively studied in the landmark STEP trials. Both are prescription-only medicines that require careful clinical assessment before switching.
When considering swapping from Mounjaro to Wegovy, it's important to understand that both treatments work by reducing appetite and promoting satiety, but through slightly different mechanisms. Wegovy's semaglutide specifically targets GLP-1 receptors in your brain's appetite centres, which may reduce food cravings and help you feel fuller after smaller meals. Your prescriber can evaluate whether this focused GLP-1 approach aligns with your individual weight management goals and medical history. The transition between treatments should always be supervised by a qualified healthcare professional to ensure optimal safety and effectiveness.
Wegovy vs Mounjaro Pricing: Transparent Costs for Swapping From Mounjaro to Wegovy
Understanding the cost implications when swapping from Mounjaro to Wegovy is crucial for planning your weight management journey. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25 to reach these final prices. Our Getting Started bundles offer convenience for dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99.
For those swapping from Mounjaro to Wegovy, our Stay Steady bundles provide consistent dosing options once you've established your optimal Wegovy dose. The Consistency ranges allow you to maintain the same dose for extended periods, with pricing reflecting the specific strength required. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment. All prices include next-day cold-chain delivery once your prescription is approved by our qualified prescribers at our GPhC-registered pharmacy (#9012878).
Clinical Evidence Supporting Swapping From Mounjaro to Wegovy Decisions
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
When considering swapping from Mounjaro to Wegovy, it's worth noting that both treatments have demonstrated significant efficacy in their respective clinical programmes, though direct head-to-head comparisons are limited due to different trial designs and patient populations. Your prescriber can help evaluate which treatment profile aligns best with your individual circumstances and health goals. The decision to switch should be based on factors including your response to current treatment, side effect profile, and personal preferences regarding dosing and administration.
How Wegovy Works: GLP-1 Mechanism for Those Swapping From Mounjaro to Wegovy
Wegovy's active ingredient, semaglutide, functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. When you eat, GLP-1 is released and signals to your brain that you're becoming full, but this response can be impaired in people with obesity. Wegovy enhances this natural signalling pathway, helping to restore normal appetite regulation and promote feelings of satiety after smaller meals. The medication works on specific receptors in your brain's appetite centres, which may help reduce food cravings and the drive to eat. Unlike some weight management approaches that rely on stimulants or appetite suppressants, Wegovy works with your body's existing hormone systems to support sustainable weight management when combined with lifestyle modifications.
Ordering Process: Swapping From Mounjaro to Wegovy Through EverydayMeds
Beginning your journey of swapping from Mounjaro to Wegovy starts with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, and weight management goals. Our qualified prescribers review every application thoroughly, with standard review times of 3 working days or express 24-hour processing available for urgent requirements. Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy and dispatched via next-day delivery using specialist cold-chain packaging to maintain optimal temperature throughout transit. The process includes detailed administration guidance and ongoing support to ensure you're confident with the transition from your previous treatment. Our clinical team remains available for questions throughout your treatment journey, providing the professional oversight essential when switching between prescription-only medicines.
Storage and Practical Considerations When Swapping From Mounjaro to Wegovy
One practical advantage when swapping from Mounjaro to Wegovy is the enhanced storage flexibility that Wegovy offers for active lifestyles. Whilst both medications require refrigeration at 2-8°C before first use, Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy particularly convenient for travel, business trips, or situations where refrigeration access might be limited. The FlexTouch pen delivery system provides precise dosing with each weekly injection, and the mandatory dose escalation schedule helps minimise potential gastrointestinal side effects as your body adjusts to treatment. Starting with 0.25mg for the first four weeks allows for gradual adaptation, progressing systematically to the 2.4mg maintenance dose over 16 weeks.
Transition Timeline: What to Expect When Swapping From Mounjaro to Wegovy
The process of swapping from Mounjaro to Wegovy requires careful consideration of timing and dose transition under prescriber guidance. Unlike switching between different strengths of the same medication, moving between tirzepatide and semaglutide involves transitioning between different molecular mechanisms, which typically requires starting Wegovy at the standard 0.25mg dose regardless of your previous Mounjaro strength. Your prescriber will determine the appropriate washout period, if any, based on your individual circumstances and how well you tolerated your previous treatment.
Most patients swapping from Mounjaro to Wegovy find that beginning with the standard Wegovy dose escalation protocol allows for optimal tolerance and effectiveness. The 16-week escalation schedule provides time for your body to adjust to semaglutide's specific GLP-1 targeting mechanism, which may feel different from Mounjaro's dual GIP and GLP-1 approach. Throughout this transition period, maintaining consistent dietary and exercise habits helps optimise your response to the new treatment while your prescriber monitors your progress and adjusts the protocol as needed.
Making Your Decision: Complete Wegovy vs Mounjaro Support at EverydayMeds
At EverydayMeds, we understand that swapping from Mounjaro to Wegovy represents an important decision in your weight management journey, which is why we provide comprehensive support for both treatments through our qualified prescribing team. Our approach ensures you have access to expert guidance whether you're considering Wegovy's focused GLP-1 approach or continuing with Mounjaro's dual-receptor targeting, with transparent pricing and reliable supply for both options. Your prescriber can help evaluate factors such as your response to current treatment, lifestyle considerations like storage requirements, and your individual health profile to determine the most appropriate choice. Both Wegovy and Mounjaro are available from EverydayMeds with the same high standards of clinical oversight, cold-chain delivery, and ongoing support. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment, using code FIRST40 for new customers or DOSE25 for returning patients to access our competitive pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
